<SEC-DOCUMENT>0001213900-24-028040-index.html : 20240329
<SEC-HEADER>0001213900-24-028040.hdr.sgml : 20240329
<ACCEPTANCE-DATETIME>20240329170056
ACCESSION NUMBER:		0001213900-24-028040
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20240329
DATE AS OF CHANGE:		20240329
EFFECTIVENESS DATE:		20240329

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Actinium Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001388320
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				880378336
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-278395
		FILM NUMBER:		24804675

	BUSINESS ADDRESS:	
		STREET 1:		100 PARK AVE., 23RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		(646) 677-3870

	MAIL ADDRESS:	
		STREET 1:		100 PARK AVE., 23RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cactus Ventures, Inc.
		DATE OF NAME CHANGE:	20070130
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>ea0202044-s8_actiniumpharma.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
Document 1 - file: ea0202044-s8_actiniumpharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea020204401ex5-1_actinium.htm
<DESCRIPTION>OPINION OF HAYNES AND BOONE, LLP
<TEXT>
Document 2 - file: ea020204401ex5-1_actinium.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ea020204401ex23-1_actinium.htm
<DESCRIPTION>CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
Document 3 - file: ea020204401ex23-1_actinium.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ea020204401ex-fee_actinium.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
Document 4 - file: ea020204401ex-fee_actinium.htm

</DOCUMENT>
</SEC-DOCUMENT>